Contact Information
Company Information
Company
Epicrispr Biotechnologies
Professional Summary
Amber Salzman serves as CEO at Epicrispr Biotechnologies. Epicrispr Biotechnologies operates in the research sector with approximately 41.0 employees. Epicrispr Biotechnologies generates annual revenue of 1000000.0. To date, Epicrispr Biotechnologies has raised 55000000.0 in total funding, with the most recent round being Series A.
Industry & Role Insights
-
•
MessageCEO tracks 2,961 executives in the research sector.
-
•
Our database includes 201,469 c suite-level executives.
Technologies
Gmail
Google Apps
Microsoft Office 365
Greenhouse.io
Google Cloud Hosting
Google Tag Manager
Gravity Forms
WordPress.org
MailChimp
Nginx
reCAPTCHA
Vimeo
Mobile Friendly
Remote
Keywords
biotechnology research
epigenetic therapy
genetic medicine
gene modulation
customized therapies
gene expression
epigenome editing
crispr technology
gene expression modulation system
gems platform
gene silencing
dna-binding proteins
guide rnas
modulator proteins
transcriptional activators
transcriptional repressors
epigenomic modulators
mutation-agnostic
therapeutic targets
in vivo delivery
ex vivo delivery
neuromuscular diseases
d4z4 methylation
facioscapulohumeral muscular dystrophy
clinical trials
fda clearance
biotechnology
crispr-cas9
epigenetic editing
gene therapy
gene regulation
molecular biology
synthetic biology
transcription factors
chromatin remodeling
gene therapy for rare diseases
dcas9
pathogenics
precision medicine
genome engineering
epigenetic biomarkers
novel therapies
biotherapeutics
nuclease-deactivated cas9
therapeutic pipeline
next-generation car-t cells
protein engineering
data science in biotech
computational genomics
genomic therapies
bioengineering advancements
health care
health
wellness & fitness
hospital & health care
Related Executives
Frequently Asked Questions
How can I contact Amber Salzman?
Amber Salzman's verified email address is available on MessageCEO. They currently work at Epicrispr Biotechnologies. Pro subscribers can access direct email addresses for over 200,000 executives.
What company does Amber Salzman lead?
Amber Salzman is CEO at Epicrispr Biotechnologies, a company in the research sector with 41.0 employees.
What industry is Amber Salzman in?
Amber Salzman works in the research industry as CEO at Epicrispr Biotechnologies. MessageCEO provides verified contact information for executives across all major industries.
Is Amber Salzman's contact information verified?
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Amber Salzman's profile is kept up-to-date with the latest available information.
Last updated: April 7, 2026
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans